Saktimayee M. Roy

783 total citations
13 papers, 632 citations indexed

About

Saktimayee M. Roy is a scholar working on Physiology, Neurology and Molecular Biology. According to data from OpenAlex, Saktimayee M. Roy has authored 13 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 5 papers in Neurology and 4 papers in Molecular Biology. Recurrent topics in Saktimayee M. Roy's work include Alzheimer's disease research and treatments (8 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Computational Drug Discovery Methods (4 papers). Saktimayee M. Roy is often cited by papers focused on Alzheimer's disease research and treatments (8 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Computational Drug Discovery Methods (4 papers). Saktimayee M. Roy collaborates with scholars based in United States, Australia and Brazil. Saktimayee M. Roy's co-authors include Linda J. Van Eldik, D. Martin Watterson, Hantamalala Ralay Ranaivo, Wenhui Hu, Lenka Munoz, Jeffrey M. Craft, Ottavio Arancio, G. Minasov, Adam D. Bachstetter and W.F. Anderson and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Saktimayee M. Roy

13 papers receiving 613 citations

Peers

Saktimayee M. Roy
Ricardo Albay United States
Inge Tomic Germany
Sigrid Graubner Germany
Ramona Belfiore Italy
Brati Das United States
Jérôme Braudeau France
Sofia Söllvander Sweden
Paul Acton United States
Ashley N. Nilson United States
Iryna Voytyuk United Kingdom
Ricardo Albay United States
Saktimayee M. Roy
Citations per year, relative to Saktimayee M. Roy Saktimayee M. Roy (= 1×) peers Ricardo Albay

Countries citing papers authored by Saktimayee M. Roy

Since Specialization
Citations

This map shows the geographic impact of Saktimayee M. Roy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saktimayee M. Roy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saktimayee M. Roy more than expected).

Fields of papers citing papers by Saktimayee M. Roy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saktimayee M. Roy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saktimayee M. Roy. The network helps show where Saktimayee M. Roy may publish in the future.

Co-authorship network of co-authors of Saktimayee M. Roy

This figure shows the co-authorship network connecting the top 25 collaborators of Saktimayee M. Roy. A scholar is included among the top collaborators of Saktimayee M. Roy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saktimayee M. Roy. Saktimayee M. Roy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Acquarone, Erica, Elentina K. Argyrousi, Ottavio Arancio, D. Martin Watterson, & Saktimayee M. Roy. (2024). The 5HT2b Receptor in Alzheimer’s Disease: Increased Levels in Patient Brains and Antagonist Attenuation of Amyloid and Tau Induced Dysfunction. Journal of Alzheimer s Disease. 98(4). 1349–1360. 5 indexed citations
2.
Braun, David J., Christopher J. McLouth, David K. Powell, et al.. (2024). A small molecule p38α MAPK inhibitor, MW150, attenuates behavioral deficits and neuronal dysfunction in a mouse model of mixed amyloid and vascular pathologies. Brain Behavior & Immunity - Health. 40. 100826–100826. 5 indexed citations
3.
4.
5.
Eldik, Linda J. Van, Lumy Sawaki, Daniel T. Laskowitz, et al.. (2020). First‐in‐Human Studies of MW01‐6‐189WH, a Brain‐Penetrant, Antineuroinflammatory Small‐Molecule Drug Candidate: Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Studies in Healthy Adult Volunteers. Clinical Pharmacology in Drug Development. 10(2). 131–143. 9 indexed citations
6.
Roy, Saktimayee M., G. Minasov, Ottavio Arancio, et al.. (2019). A Selective and Brain Penetrant p38αMAPK Inhibitor Candidate for Neurologic and Neuropsychiatric Disorders That Attenuates Neuroinflammation and Cognitive Dysfunction. Journal of Medicinal Chemistry. 62(11). 5298–5311. 39 indexed citations
7.
Tavares, Maurício T., Hendra Gunosewoyo, David R. Piper, et al.. (2019). Evaluation of Protein Kinase Inhibitors with PLK4 Cross-Over Potential in a Pre-Clinical Model of Cancer. International Journal of Molecular Sciences. 20(9). 2112–2112. 39 indexed citations
8.
Zhou, Zhengqiu, Adam D. Bachstetter, Claudia Späni, et al.. (2017). Retention of normal glia function by an isoform-selective protein kinase inhibitor drug candidate that modulates cytokine production and cognitive outcomes. Journal of Neuroinflammation. 14(1). 75–75. 27 indexed citations
9.
Maphis, Nicole, Shanya Jiang, Guixiang Xu, et al.. (2016). Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology. Alzheimer s Research & Therapy. 8(1). 54–54. 110 indexed citations
10.
Roy, Saktimayee M., Valerie Grum‐Tokars, James P. Schavocky, et al.. (2015). Targeting Human Central Nervous System Protein Kinases: An Isoform Selective p38αMAPK Inhibitor That Attenuates Disease Progression in Alzheimer’s Disease Mouse Models. ACS Chemical Neuroscience. 6(4). 666–680. 78 indexed citations
11.
Watterson, D. Martin, Valerie Grum‐Tokars, Saktimayee M. Roy, et al.. (2013). Development of Novel In Vivo Chemical Probes to Address CNS Protein Kinase Involvement in Synaptic Dysfunction. PLoS ONE. 8(6). e66226–e66226. 64 indexed citations
12.
Munoz, Lenka, Hantamalala Ralay Ranaivo, Saktimayee M. Roy, et al.. (2007). A novel p38α MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model. Journal of Neuroinflammation. 4(1). 21–21. 197 indexed citations
13.
Hu, Wenhui, Hantamalala Ralay Ranaivo, Saktimayee M. Roy, et al.. (2006). Development of a novel therapeutic suppressor of brain proinflammatory cytokine up-regulation that attenuates synaptic dysfunction and behavioral deficits. Bioorganic & Medicinal Chemistry Letters. 17(2). 414–418. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ricardo Albay Breakdown of academic impact, for papers by Inge Tomic Breakdown of academic impact, for papers by Sigrid Graubner Breakdown of academic impact, for papers by Ramona Belfiore Breakdown of academic impact, for papers by Brati Das Breakdown of academic impact, for papers by Jérôme Braudeau Breakdown of academic impact, for papers by Sofia Söllvander Breakdown of academic impact, for papers by Paul Acton Breakdown of academic impact, for papers by Ashley N. Nilson Breakdown of academic impact, for papers by Iryna Voytyuk
Rankless by CCL
2026